Status:
UNKNOWN
Non-Pharmacological Treatment of Psychosis
Lead Sponsor:
Haukeland University Hospital
Conditions:
Psychosis; Schizophrenia-Like
Eligibility:
All Genders
Brief Summary
The objectives of the project are to investigate feasibility, safety, and health-related outcomes in patients with psychosis who choose not to use antipsychotic drugs (APs). The instruction from the M...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Fulfillment of diagnostic criteria for schizophrenia or related disorder (corresponding to chapter F2 in the ICD-10)
- The clinician responsible for the treatment must consider nonpharmacological treatment to be professionally justifiable in the patient in question
- Patient being able/ capable of providing informed consent
- Patient receiving active treatment including different psychosocial treatments
- Patient having a treatment plan and a crisis resolution plan.
- Exclusion Criteria Not fullfilling inclusion criteria
Exclusion
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04051775
Start Date
December 1 2018
End Date
June 30 2023
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland Univsersity Hospital
Bergen, Norway, 5021